Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Adeno-associated viral vector containing DNA encoding an RNAi targeting rhodopsin / adeno-associated viral vector containing a rhodopsin gene

EU orphan designation number: EU/3/10/817   
Active ingredient: Adeno-associated viral vector containing DNA encoding an RNAi targeting rhodopsin / adeno-associated viral vector containing a rhodopsin gene
Indication: Treatment of rhodopsin-linked retinitis pigmentosa
Sponsor: Spark Therapeutics Ireland Ltd
The Tower, Trinity Technology & Enterprise Campus, Pearse Street, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/01/2011 Orphan designation EMA/OD/098/10 (2010)9530 of 17/12/2010
09/03/2017 Change of name and/or address of sponsor